IMFINZI 50 mg/ml concentrate for solution for infusion | medicines.ie

Company: AstraZeneca Pharmaceuticals (Ireland) DAC
Active Ingredient: Durvalumab
Strength: Durvalumab: 50 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/18/1322/001	50 mg	L01FF03	Concentrate for solution for infusion
EU/1/18/1322/002	50 mg	L01FF03	Concentrate for solution for infusion

Licence number: EU/1/18/1322/001
Strength: 50 mg
ATC Code: L01FF03
Dosage Form: Concentrate for solution for infusion

Licence number: EU/1/18/1322/002
Strength: 50 mg
ATC Code: L01FF03
Dosage Form: Concentrate for solution for infusion

AstraZeneca Pharmaceuticals (Ireland) DAC

College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925, D15 R925 Dublin

Website: https://contactazmedical.astrazeneca.com
Telephone: +3531800800899
Email: mipqc.ireland@astrazeneca.com